Thomas Hutson, DO, PharmD, Texas Oncology–Baylor
Advertisement
Articles by Thomas Hutson, DO, PharmD, Texas Oncology–Baylor
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Pumitamig Plus Chemo Demonstrates Encouraging Efficacy in Frontline NSCLC
2
Iza-Bren Improves Survival in Unresectable, Locally Advanced or Metastatic TNBC
3
Mocertatug Rezetecan Drives Rapid, Deep Responses in Platinum-Resistant Ovarian and Recurrent/Advanced Endometrial Cancer
4
Zongertinib, Sevabertinib Reshape Treatment Landscape for Patients With HER2-Mutated NSCLC
5